An automated histological classification system for precision diagnostics of kidney allografts

Archive ouverte

Yoo, Daniel | Goutaudier, Valentin | Divard, Gillian | Gueguen, Juliette | Astor, Brad C. | Aubert, Olivier | Raynaud, Marc | Demir, Zeynep | Hogan, Julien | Weng, Patricia | Smith, Jodi | Garro, Rouba | Warady, Bradley | Zahr, Rima | Sablik, Marta | Twombley, Katherine | Couzi, Lionel | Berney, Thierry | Boyer, Olivia | Duong van Huyen, Jean-Paul | Giral, Magali | Alsadi, Alaa | Gourraud, Pierre-Antoine | Morelon, Emmanuel | Le Quintrec, Moglie | Brouard, Sophie | Legendre, Christophe | Anglicheau, Dany | Villard, Jean | Zhong, Weixiong | Kamar, Nassim | Bestard, Oriol | Djamali, Arjang | Budde, Klemens | Haas, Mark | Lefaucheur, Carmen | Rabant, Marion | Loupy, Alexandre

Edité par CCSD ; Nature Publishing Group -

International audience. For three decades, the international Banff classification has been the gold standard for kidney allograft rejection diagnosis, but this system has become complex over time with the integration of multimodal data and rules, leading to misclassifications that can have deleterious therapeutic consequences for patients. To improve diagnosis, we developed a decision-support system, based on an algorithm covering all classification rules and diagnostic scenarios, that automatically assigns kidney allograft diagnoses. We then tested its ability to reclassify rejection diagnoses for adult and pediatric kidney transplant recipients in three international multicentric cohorts and two large prospective clinical trials, including 4,409 biopsies from 3,054 patients (62.05% male and 37.95% female) followed in 20 transplant referral centers in Europe and North America. In the adult kidney transplant population, the Banff Automation System reclassified 83 out of 279 (29.75%) antibody-mediated rejection cases and 57 out of 105 (54.29%) T cell-mediated rejection cases, whereas 237 out of 3,239 (7.32%) biopsies diagnosed as non-rejection by pathologists were reclassified as rejection. In the pediatric population, the reclassification rates were 8 out of 26 (30.77%) for antibody-mediated rejection and 12 out of 39 (30.77%) for T cell-mediated rejection. Finally, we found that reclassification of the initial diagnoses by the Banff Automation System was associated with an improved risk stratification of long-term allograft outcomes. This study demonstrates the potential of an automated histological classification to improve transplant patient care by correcting diagnostic errors and standardizing allograft rejection diagnoses

Suggestions

Du même auteur

Microvascular Inflammation of Kidney Allografts and Clinical Outcomes

Archive ouverte | Sablik, Marta | CCSD

International audience. Background: The heterogeneous clinical presentation of graft microvascular inflammation poses a major challenge to successful kidney transplantation. The effect of microvascular inflammation ...

Antibody Mediated Rejection and T-cell Mediated Rejection Molecular Signatures Using Next-Generation Sequencing in Kidney Transplant Biopsies

Archive ouverte | Cortes Garcia, Esteban | CCSD

International audience. Recently, interest in transcriptomic assessment of kidney biopsies has been growing. This study investigates the use of NGS to identify gene expression changes and analyse the pathways involv...

Archetypal Analysis of Kidney Allograft Biopsies Using Next-generation Sequencing Technology

Archive ouverte | Cortes Garcia, Esteban | CCSD

International audience. Background : In kidney transplantation, molecular diagnostics may be a valuable approach to improve the precision of the diagnosis. Using next-generation sequencing (NGS), we aimed to identi...

Chargement des enrichissements...